Article
Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer.
Breast cancer research and treatment - 1 Jun 2011
Rajan Suja S, Lyman Gary H, Carpenter William R, Stearns Sally C
Abstract excerpt
Chemotherapy is vital for breast cancer management, but early onset toxicities like neutropenia hinder its administration. Primary prophylactic (PP) use of colony- stimulating factors (CSF) helps prevent neutropenia and ensures successful chemotherapy completion. Nevertheless, lack of specific guidelines for CSF administration in older patients has lead to unexplained geographic and racial, and counter-intuitive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.